Literature DB >> 27743930

Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism.

Amit Modgil1, Manasa L Parakala1, Michael A Ackley2, James J Doherty2, Stephen J Moss3, Paul A Davies4.   

Abstract

The neuroactive steroid (NAS) tetrahydrodeoxycorticosterone (THDOC) increases protein kinase C (PKC) mediated phosphorylation of extrasynaptic GABAA receptor (GABAAR) subunits leading to increased surface expression of α4/β3 subunit-containing extrasynaptic GABAARs, leading to a sustained increase in GABAAR tonic current density. Whether other naturally occurring and synthetic NASs share both an allosteric and metabotropic action on GABAARs is unknown. Here, we examine the allosteric and metabotropic properties of allopregnanolone (ALLO), and synthetic NASs SGE-516 and ganaxolone. ALLO, SGE-516, and ganaxolone all allosterically enhanced prototypical synaptic and extrasynaptic recombinant GABAARs. In dentate gyrus granule cells (DGGCs) all three NASs, when applied acutely, allosterically enhanced tonic and phasic GABAergic currents. In separate experiments, slices were exposed to NASs for 15 min, and then transferred to a steroid naïve recording chamber followed by ≥ 30 min wash before tonic currents were measured. A sustained increase in tonic current was observed following exposure to ALLO, or SGE-516 and was prevented by inhibiting PKC with GF 109203X. No increase in tonic current was observed with exposure to ganaxolone. In agreement with the observations of an increased tonic current, the NASs ALLO and SGE-516 increased the phosphorylation and surface expression of the β3 subunit-containing GABAARs. Our studies demonstrate that neuroactive steroids have differential abilities to induce sustained increases in the efficacy of tonic inhibition by promoting GABAAR phosphorylation and membrane trafficking dependent on PKC activity. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dentate gyrus; GABA receptor; Neuroactive steroid; Protein kinase C (PKC); Tonic inhibition

Mesh:

Substances:

Year:  2016        PMID: 27743930      PMCID: PMC5148695          DOI: 10.1016/j.neuropharm.2016.10.010

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  29 in total

1.  A significant part of native gamma-aminobutyric AcidA receptors containing alpha4 subunits do not contain gamma or delta subunits.

Authors:  E Bencsits; V Ebert; V Tretter; W Sieghart
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

2.  Neuroactive Steroids. 1. Positive Allosteric Modulators of the (γ-Aminobutyric Acid)A Receptor: Structure-Activity Relationships of Heterocyclic Substitution at C-21.

Authors:  Gabriel Martinez Botella; Francesco G Salituro; Boyd L Harrison; Richard T Beresis; Zhu Bai; Kaisheng Shen; Gabriel M Belfort; Carlos M Loya; Michael A Ackley; Scott J Grossman; Ethan Hoffmann; Shiling Jia; Jiamiao Wang; James J Doherty; Albert J Robichaud
Journal:  J Med Chem       Date:  2015-04-14       Impact factor: 7.446

3.  GABAA receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol.

Authors:  D Chandra; F Jia; J Liang; Z Peng; A Suryanarayanan; D F Werner; I Spigelman; C R Houser; R W Olsen; N L Harrison; G E Homanics
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-27       Impact factor: 11.205

4.  Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

Authors:  Giulia Curia; Thomas Papouin; Philippe Séguéla; Massimo Avoli
Journal:  Cereb Cortex       Date:  2008-09-11       Impact factor: 5.357

5.  Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptors.

Authors:  Valerie B Caraiscos; Erin M Elliott; Kong E You-Ten; Victor Y Cheng; Delia Belelli; J Glen Newell; Michael F Jackson; Jeremy J Lambert; Thomas W Rosahl; Keith A Wafford; John F MacDonald; Beverley A Orser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

6.  Compromising the phosphodependent regulation of the GABAAR β3 subunit reproduces the core phenotypes of autism spectrum disorders.

Authors:  Thuy N Vien; Amit Modgil; Armen M Abramian; Rachel Jurd; Joshua Walker; Nicholas J Brandon; Miho Terunuma; Uwe Rudolph; Jamie Maguire; Paul A Davies; Stephen J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

7.  Neurosteroids promote phosphorylation and membrane insertion of extrasynaptic GABAA receptors.

Authors:  Armen M Abramian; Eydith Comenencia-Ortiz; Amit Modgil; Thuy N Vien; Yasuko Nakamura; Yvonne E Moore; Jamie L Maguire; Miho Terunuma; Paul A Davies; Stephen J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  Modulation of neurosteroid potentiation by protein kinases at synaptic- and extrasynaptic-type GABAA receptors.

Authors:  Joanna M Adams; Philip Thomas; Trevor G Smart
Journal:  Neuropharmacology       Date:  2014-09-30       Impact factor: 5.250

9.  Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus.

Authors:  Miho Terunuma; Jianwei Xu; Mansi Vithlani; Werner Sieghart; Josef Kittler; Menelas Pangalos; Philip G Haydon; Douglas A Coulter; Stephen J Moss
Journal:  J Neurosci       Date:  2008-01-09       Impact factor: 6.167

10.  Protein kinase C regulates tonic GABA(A) receptor-mediated inhibition in the hippocampus and thalamus.

Authors:  Damian P Bright; Trevor G Smart
Journal:  Eur J Neurosci       Date:  2013-09-16       Impact factor: 3.386

View more
  23 in total

1.  Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABAA receptors.

Authors:  Manasa L Parakala; Yihui Zhang; Amit Modgil; Jayashree Chadchankar; Thuy N Vien; Michael A Ackley; James J Doherty; Paul A Davies; Stephen J Moss
Journal:  J Biol Chem       Date:  2019-06-25       Impact factor: 5.157

Review 2.  Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy.

Authors:  Shu-Hui Chuang; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2017-11-15       Impact factor: 4.030

Review 3.  Stress and Seizures: Space, Time and Hippocampal Circuits.

Authors:  B G Gunn; T Z Baram
Journal:  Trends Neurosci       Date:  2017-09-12       Impact factor: 13.837

4.  Decreased surface expression of the δ subunit of the GABAA receptor contributes to reduced tonic inhibition in dentate granule cells in a mouse model of fragile X syndrome.

Authors:  Nianhui Zhang; Zechun Peng; Xiaoping Tong; A Kerstin Lindemeyer; Yliana Cetina; Christine S Huang; Richard W Olsen; Thomas S Otis; Carolyn R Houser
Journal:  Exp Neurol       Date:  2017-08-16       Impact factor: 5.330

5.  The relationship between GABA and stress: 'it's complicated'.

Authors:  Jamie Maguire
Journal:  J Physiol       Date:  2018-04-16       Impact factor: 5.182

6.  The 5α-Reductase Inhibitor Finasteride Exerts Neuroprotection Against Ischemic Brain Injury in Aged Male Rats.

Authors:  Motoki Tanaka; Takunori Ogaeri; Mikhail Samsonov; Masahiro Sokabe
Journal:  Transl Stroke Res       Date:  2018-03-25       Impact factor: 6.829

7.  Non-sedative cortical EEG signatures of allopregnanolone and functional comparators.

Authors:  Peter M Lambert; Richard Ni; Ann Benz; Nicholas R Rensing; Michael Wong; Charles F Zorumski; Steven Mennerick
Journal:  Neuropsychopharmacology       Date:  2022-09-27       Impact factor: 8.294

Review 8.  A Rationale for Allopregnanolone Treatment of Alcohol Use Disorders: Basic and Clinical Studies.

Authors:  A Leslie Morrow; Giorgia Boero; Patrizia Porcu
Journal:  Alcohol Clin Exp Res       Date:  2019-12-17       Impact factor: 3.455

9.  3β-Methyl-Neurosteroid Analogs Are Preferential Positive Allosteric Modulators and Direct Activators of Extrasynaptic δ-Subunit γ-Aminobutyric Acid Type A Receptors in the Hippocampus Dentate Gyrus Subfield.

Authors:  Shu-Hui Chuang; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2018-03-30       Impact factor: 4.030

Review 10.  Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women.

Authors:  Doodipala Samba Reddy
Journal:  J Neuroendocrinol       Date:  2021-09-10       Impact factor: 3.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.